Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)

Market Cap	4.75B +6.0%
Revenue (ttm)	1.55B +0.4%
Net Income	162.24M -3.7%
EPS	0.72 -2.2%
Shares Out	228.22M
PE Ratio	29.00
Forward PE	n/a
Dividend	0.42 (2.02%)
Ex-Dividend Date	May 29, 2026

Volume	46,752,939
Open	17.05
Previous Close	20.80
Day's Range	17.05 - 22.30
52-Week Range	14.20 - 34.56
Beta	-0.07
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHE:003020

Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients in China and internationally. The company offers active pharmaceutical ingredients, which includes felodipine, urea, paeonol, doxazosin mesylate, prilocaine, nifedipine, azilsartan kamedoxomil, methylphenidate hydrochloride, dexmethylphenidate HCL, dioctyl sulfosuccinate sodium salt, and DMSA. It also provides intermediate products, such as sodium paeonolsilate, methy2-(2,3-dichlor...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 1,465
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 003020

Financial Performance

In 2025, SHE:003020's revenue was 1.55 billion, an increase of 2.33% compared to the previous year's 1.52 billion. Earnings were 165.20 million, an increase of 2.86%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 15, 2026

Data Sources Report a data error